Baxter International | BAX - Market Capitalization


Baxter International reported $8.51B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
AngioDynamics USD 511M 94M Sep/2025
Artivion USD 2.18B 176M Dec/2025
AtriCure USD 1.97B 215M Dec/2025
Avanos Medical USD 521M 15M Dec/2025
Baxter International USD 9.82B 1.87B Dec/2025
Becton, Dickinson and Co. USD 55.29B 1.64B Dec/2025
Boston Scientific USD 141.35B 3.31B Dec/2025
Cooper Companies USD 15.95B 2.05B Dec/2025
Dexcom USD 25.88B 503M Dec/2025
Edwards Lifesciences USD 49.47B 3.81B Dec/2025
Fresenius EUR 27.59B 889.91M Dec/2025
Globus Medical USD 11.69B 3.95B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
ICU Medical USD 3.52B 561M Dec/2025
Insulet USD 20B 1.74B Dec/2025
Integra LifeSciences USD 967M 150M Dec/2025
Intuitive Surgical USD 200.77B 40.45B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Laboratory Of America USD 20.8B 3.03B Dec/2025
Masimo USD 6.84B 839M Dec/2025
Merit Medical Systems USD 5.23B 297M Dec/2025
Quest Diagnostics USD 19.3B 2.01B Dec/2025
Smith & Nephew USD 3.77B 9.55B Apr/2026
Stryker USD 134.41B 6.92B Dec/2025
Tandem Diabetes Care USD 1.49B 670M Dec/2025
Teleflex USD 5.39B 91M Dec/2025
Zimmer Biomet Holdings USD 17.82B 1.69B Dec/2025